MedTrace Logo

Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial

NCT04494516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183

Last updated 2023-07-12

No results posted yet for this study

Summary

This qualitative study is designed to elicit the perspectives of relevant stakeholders to adapt a community-based TB/HIV intervention aimed on providing home-based TB prevention treatment (TPT) initiation for child TB contacts, to design its implementation strategy and, post intervention, to assess lessons learned for future scale up. Participants will include policy makers and health system managers, nurse and physician providers, community health team members, and child caregivers of TB-exposed children. Stakeholders will be asked to participate in two interviews, one prior to the cluster randomized trial assessing this intervention and one after the cluster randomized trial. Trained interviewers will conduct 1-hour semi-structured in-depth interviews that will be audio-recorded, translated and transcribed for thematic analysis using a priori and emergent domains of interest. Free-listing, ranking exercises and cultural consensus will be used to identify context-specific intervention adaptations and implementation strategies.

Conditions

  • Tuberculosis Infection
  • Tuberculosis Prevention

Sponsors & Collaborators

  • UNITAID

    collaborator OTHER

  • Aurum Institute

    collaborator OTHER

  • KNCV Tuberculosis Foundation

    collaborator OTHER

  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Nicole Salazar-Austin, MD · Johns Hopkins School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Ethiopia
  • South Africa

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04494516 on ClinicalTrials.gov